{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ondansétron : Questions médicales les plus fréquentes",
"headline": "Ondansétron : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ondansétron : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-10",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ondansétron"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Carbazoles",
"url": "https://questionsmedicales.fr/mesh/D002227",
"about": {
"@type": "MedicalCondition",
"name": "Carbazoles",
"code": {
"@type": "MedicalCode",
"code": "D002227",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.148"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Ondansétron",
"alternateName": "Ondansetron",
"code": {
"@type": "MedicalCode",
"code": "D017294",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Leonid Kagan",
"url": "https://questionsmedicales.fr/author/Leonid%20Kagan",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA."
}
},
{
"@type": "Person",
"name": "Simon Haroutounian",
"url": "https://questionsmedicales.fr/author/Simon%20Haroutounian",
"affiliation": {
"@type": "Organization",
"name": "Division of Clinical and Translational Research and Washington University Pain Center, Department of Anesthesiology, Washington University School of Medicine, St Louis, MO, USA."
}
},
{
"@type": "Person",
"name": "Michele Jonsson Funk",
"url": "https://questionsmedicales.fr/author/Michele%20Jonsson%20Funk",
"affiliation": {
"@type": "Organization",
"name": "Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA."
}
},
{
"@type": "Person",
"name": "Stephen B Freedman",
"url": "https://questionsmedicales.fr/author/Stephen%20B%20Freedman",
"affiliation": {
"@type": "Organization",
"name": "Sections of Pediatric Emergency Medicine and Gastroenterology, Departments of Pediatrics and Emergency Medicine, Alberta Children's Hospital, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. Stephen.freedman@ahs.ca."
}
},
{
"@type": "Person",
"name": "Mingyu Duan",
"url": "https://questionsmedicales.fr/author/Mingyu%20Duan",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, Shenyang Key Laboratory of Functional Drug Carrier Materials, Shenyang Pharmaceutical University, Shenyang, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Comparative anatomic and symptomatic recurrence outcomes of diaphragmatic suture cruroplasty versus biosynthetic mesh reinforcement in robotic hiatal and paraesophageal hernia repair.",
"datePublished": "2024-09-13",
"url": "https://questionsmedicales.fr/article/39271508",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00464-024-11257-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Flexible Artificial Tactility with Excellent Robustness and Temperature Tolerance Based on Organohydrogel Sensor Array for Robot Motion Detection and Object Shape Recognition.",
"datePublished": "2024-09-10",
"url": "https://questionsmedicales.fr/article/39255513",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/adma.202408193"
}
},
{
"@type": "ScholarlyArticle",
"name": "Is bicortical femoral pin insertion safe for Image-based Robotic Knee Arthroplasty Surgery ? A comparative complications analysis in 970 Consecutive Cases.",
"datePublished": "2024-09-07",
"url": "https://questionsmedicales.fr/article/39251024",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jisako.2024.100317"
}
},
{
"@type": "ScholarlyArticle",
"name": "Feasibility and safety study of advanced prostate biopsy robot system based on MR-TRUS Image flexible fusion technology in animal experiments.",
"datePublished": "2024-08-28",
"url": "https://questionsmedicales.fr/article/39209114",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.slast.2024.100184"
}
},
{
"@type": "ScholarlyArticle",
"name": "Safety of robotic double-flap technique following proximal gastrectomy in the introductory phase compared with laparoscopic procedure: a propensity score-matched analysis.",
"datePublished": "2024-08-19",
"url": "https://questionsmedicales.fr/article/39160307",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00464-024-11156-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérocycliques 3 noyaux",
"item": "https://questionsmedicales.fr/mesh/D006575"
},
{
"@type": "ListItem",
"position": 5,
"name": "Carbazoles",
"item": "https://questionsmedicales.fr/mesh/D002227"
},
{
"@type": "ListItem",
"position": 6,
"name": "Ondansétron",
"item": "https://questionsmedicales.fr/mesh/D017294"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ondansétron - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ondansétron",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ondansétron",
"description": "Comment l'ondansétron est-il prescrit ?\nQuels tests sont nécessaires avant de prendre de l'ondansétron ?\nL'ondansétron est-il efficace pour tous les patients ?\nPeut-on utiliser l'ondansétron en cas de grossesse ?\nQuels sont les signes d'une réaction allergique à l'ondansétron ?",
"url": "https://questionsmedicales.fr/mesh/D017294?mesh_terms=Robotics&page=999#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ondansétron",
"description": "Quels symptômes l'ondansétron traite-t-il ?\nL'ondansétron peut-il provoquer des effets secondaires ?\nQuels sont les symptômes d'une surdose d'ondansétron ?\nL'ondansétron soulage-t-il les nausées de voyage ?\nPeut-on ressentir des vertiges avec l'ondansétron ?",
"url": "https://questionsmedicales.fr/mesh/D017294?mesh_terms=Robotics&page=999#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ondansétron",
"description": "Comment l'ondansétron aide-t-il à prévenir les nausées ?\nPeut-on utiliser l'ondansétron pour prévenir les vomissements ?\nL'ondansétron est-il utilisé en soins palliatifs ?\nY a-t-il des alternatives à l'ondansétron pour la prévention ?\nL'ondansétron est-il efficace pour les nausées de grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D017294?mesh_terms=Robotics&page=999#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ondansétron",
"description": "Comment l'ondansétron est-il administré ?\nQuelle est la posologie standard de l'ondansétron ?\nL'ondansétron peut-il être combiné avec d'autres médicaments ?\nCombien de temps avant un traitement doit-on prendre l'ondansétron ?\nL'ondansétron est-il efficace pour les nausées de chimiothérapie ?",
"url": "https://questionsmedicales.fr/mesh/D017294?mesh_terms=Robotics&page=999#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ondansétron",
"description": "Quelles complications peuvent survenir avec l'ondansétron ?\nL'ondansétron peut-il causer des problèmes cardiaques ?\nQuels sont les risques d'interaction médicamenteuse avec l'ondansétron ?\nL'ondansétron peut-il entraîner une dépendance ?\nQuels effets à long terme de l'ondansétron sont connus ?",
"url": "https://questionsmedicales.fr/mesh/D017294?mesh_terms=Robotics&page=999#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ondansétron",
"description": "Qui est à risque d'effets secondaires avec l'ondansétron ?\nLes personnes âgées sont-elles plus à risque avec l'ondansétron ?\nY a-t-il des conditions médicales qui augmentent le risque ?\nLes femmes enceintes sont-elles à risque avec l'ondansétron ?\nLes patients sous anticoagulants doivent-ils être prudents ?",
"url": "https://questionsmedicales.fr/mesh/D017294?mesh_terms=Robotics&page=999#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment l'ondansétron est-il prescrit ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est prescrit pour prévenir les nausées post-opératoires ou induites par la chimiothérapie."
}
},
{
"@type": "Question",
"name": "Quels tests sont nécessaires avant de prendre de l'ondansétron ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucun test spécifique n'est requis, mais l'historique médical est évalué."
}
},
{
"@type": "Question",
"name": "L'ondansétron est-il efficace pour tous les patients ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Son efficacité peut varier selon le type de traitement et la réponse individuelle."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'ondansétron en cas de grossesse ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Son utilisation doit être discutée avec un médecin, car les risques doivent être évalués."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une réaction allergique à l'ondansétron ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent éruption cutanée, démangeaisons, ou gonflement du visage."
}
},
{
"@type": "Question",
"name": "Quels symptômes l'ondansétron traite-t-il ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il traite principalement les nausées et vomissements post-chirurgicaux ou chimiothérapeutiques."
}
},
{
"@type": "Question",
"name": "L'ondansétron peut-il provoquer des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des maux de tête ou de la constipation peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une surdose d'ondansétron ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles de la vision, des palpitations et des évanouissements."
}
},
{
"@type": "Question",
"name": "L'ondansétron soulage-t-il les nausées de voyage ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il n'est pas recommandé pour les nausées liées au mal des transports."
}
},
{
"@type": "Question",
"name": "Peut-on ressentir des vertiges avec l'ondansétron ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des vertiges peuvent survenir comme effet secondaire chez certains patients."
}
},
{
"@type": "Question",
"name": "Comment l'ondansétron aide-t-il à prévenir les nausées ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il bloque les récepteurs de la sérotonine, réduisant ainsi les signaux de nausée."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'ondansétron pour prévenir les vomissements ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est efficace pour prévenir les vomissements liés à la chimiothérapie et à la chirurgie."
}
},
{
"@type": "Question",
"name": "L'ondansétron est-il utilisé en soins palliatifs ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être utilisé pour soulager les nausées chez les patients en soins palliatifs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des alternatives à l'ondansétron pour la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres antiémétiques comme le métoclopramide peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "L'ondansétron est-il efficace pour les nausées de grossesse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut être prescrit, mais son utilisation doit être soigneusement évaluée par un médecin."
}
},
{
"@type": "Question",
"name": "Comment l'ondansétron est-il administré ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut être administré par voie orale, intraveineuse ou sous forme de comprimés dissous."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie standard de l'ondansétron ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie varie, mais elle est généralement de 4 à 8 mg, selon le traitement."
}
},
{
"@type": "Question",
"name": "L'ondansétron peut-il être combiné avec d'autres médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être utilisé avec d'autres antiémétiques, mais sous supervision médicale."
}
},
{
"@type": "Question",
"name": "Combien de temps avant un traitement doit-on prendre l'ondansétron ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est généralement recommandé de le prendre 30 minutes avant le début du traitement."
}
},
{
"@type": "Question",
"name": "L'ondansétron est-il efficace pour les nausées de chimiothérapie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est très efficace pour prévenir les nausées induites par la chimiothérapie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'ondansétron ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications rares incluent des troubles cardiaques et des réactions allergiques graves."
}
},
{
"@type": "Question",
"name": "L'ondansétron peut-il causer des problèmes cardiaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut provoquer des arythmies cardiaques chez certains patients sensibles."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'interaction médicamenteuse avec l'ondansétron ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut interagir avec des médicaments comme les antidépresseurs et certains analgésiques."
}
},
{
"@type": "Question",
"name": "L'ondansétron peut-il entraîner une dépendance ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'ondansétron n'est pas considéré comme une substance addictive."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme de l'ondansétron sont connus ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme ne sont pas bien documentés, mais une surveillance est recommandée."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'effets secondaires avec l'ondansétron ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients avec des antécédents de maladies cardiaques ou d'allergies sont à risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque avec l'ondansétron ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets secondaires de l'ondansétron."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conditions médicales qui augmentent le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme l'insuffisance hépatique peuvent augmenter le risque d'effets indésirables."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles à risque avec l'ondansétron ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être à risque, et l'utilisation doit être soigneusement évaluée par un médecin."
}
},
{
"@type": "Question",
"name": "Les patients sous anticoagulants doivent-ils être prudents ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une attention particulière est nécessaire en raison des risques d'interactions médicamenteuses."
}
}
]
}
]
}
Hiatal and paraesophageal hernia (HH/PEH) recurrence is the most common cause of failure after gastroesophageal anti-reflux surgery. Crural reinforcement with mesh has been suggested to address this i...
Data of patients who underwent robotic HH/PEH repair with suture cruroplasty with or without biosynthetic mesh reinforcement between January 2012 and April 2024 were retrospectively reviewed. Gastroes...
Out of the 503 patients in the study, 308 had undergone biosynthetic mesh repair, while 195 had suture-only repair. After the surgery, both groups demonstrated comparable improvements in symptoms. Sho...
After more than a year of follow-up, it has been found that using biosynthetic mesh for medium and large hiatal or paraesophageal hernia repair significantly reduces the likelihood of both anatomic an...
Hydrogel-based flexible artificial tactility is equipped to intelligent robots to mimic human mechanosensory perception. However, it remains a great challenge for hydrogel sensors to maintain flexibil...
Limited data exists on complications associated with robotic image-based system in knee arthroplasty. This study aims to document complications in robotic arm-assisted knee arthroplasties, and evaluat...
All patients undergoing primary knee arthroplasty with the image-based robotic system (Mako, Stryker, Mako Surgical Corp., Fort Lauderdale, FL, USA) from 1...
A total of 970 consecutive cases (median age 69.3 years) were analyzed. The unicortical group comprised 651 cases, while the bicortical group 319. The incidence of non-system-related complications was...
Minimal system-specific overall complications indicate that robotic arm-assisted surgery is safe. The bicortical diaphyseal femoral pin insertion method does not increase the complication rates compar...
III....
The advanced prostate biopsy robot system has broad application prospects in clinical practice, but due to the deformation and distortion between MR-TRUS (magnetic resonance transrectal ultrasound) im...
Proximal gastrectomy (PG) is recommended for upper-third gastric cancer and esophagogastric junction (EGJ) cancer, preserving organ function while reducing postoperative symptoms. The double-flap tech...
This retrospective study compared the outcomes of RPG-DFT with LPG-DFT. Data from 402 patients (321 LPG-DFT, 81 RPG-DFT) between 2009 and 2023 were analyzed. Propensity score matching balanced patient...
The surgery time of LPG-DFT has stabilized in patients since 2016. Thus, LPG-DFT from 2016 was defined as a stable procedure. RPG-DFT was started in 2019, after minimally invasive DFT reconstruction h...
This study demonstrated the safety of RPG-DFT in the introductory phase for EGJ and upper-third stomach tumors, with outcomes comparable to stable LPG-DFT. RPG-DFT offers shorter reconstruction time a...
The safety and efficacy of single-port and multi-port robot-assisted partial nephrectomy (SP-RAPN and MP-RAPN, respectively) were assessed for treating partial nephrectomy in this study. A systematic ...
This study aimed to compare the efficacy of robot-assisted partial nephrectomy for completely endophytic renal tumors with the reported outcomes of conventional laparoscopic partial nephrectomy and in...
We conducted a prospective, multicenter, single-arm, open-label trial across 17 academic centers in Japan. Patients with endophytic renal tumors classified as cT1, cN0, cM0 were included and underwent...
Our per-protocol analysis included 98 participants. The mean warm ischemic time was 20.3 min (99% confidence interval 18.3-22.3; p < 0.0001 vs. 25.2). None of the 98 participants had a positive surgic...
Robot-assisted partial nephrectomy for completely endophytic renal tumors offers a shorter warm ischemia time and comparable positive surgical margin rate compared with conventional laparoscopic parti...
Transoral robotic surgery (TORS) performed after neoadjuvant chemotherapy (NAC) is a promising treatment for advanced-stage oropharyngeal carcinoma (OPSCC) able to reduce the adjuvant therapy administ...
A retrospective bi-centric study was conducted to analyze NAC + TORS versus upfront TORS patients. A 1:1 propensity score matching was used to compare the two groups....
Among the 300 patients with stage III-IV OPSCC, 204 patients were matched for comparing NAC + TORS versus upfront TORS. Between the two groups, no significant difference was observed in recurrences an...
NAC followed by TORS for locoregionally advanced OPSCC demonstrated to achieve non-inferior survival outcomes to upfront surgery, while in the p16-positive population allowed to significantly spare ad...
The objective of this study is to analyze the association between surgical day of the week and distance traveled with prolonged length of stay (LOS) following robotic-assisted partial nephrectomy (RAP...
Robotic pancreaticoduodenectomy (RPD) is used more commonly, but this surge is mostly based on observational data. This meta-analysis aimed to compare the short-term outcomes between RPD and open panc...
We searched PubMed, Cochrane Library, Embase, and Web of Science databases for RCTs and PSM studies comparing RPD and OPD. Risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (C...
Twenty-four studies, encompassing two RCTs and 22 PSM studies, were included, with a total of 9393 patients (RPD group: 3919 patients; OPD group: 5474 patients). Although RPD was associated with a lon...
Although some short-term outcomes were similar between RPD and OPD, RPD exhibited reduced intraoperative blood loss, shorter hospital stays, lower wound infection, and blood transfusion rates. In the ...